Investigate, Following Cataract Surgery With IOL in Conjunction With Intracanalicular Dexamethasone Insert

Inclusion Criteria: * Age 18 years and older * Been diagnosed with POAG or OHTN and MIGS (iStent, iStent inject or KDB) has been planned * Unilateral or bilateral cataract surgery with IOL has been planned * Willing and able to comply with clinic visits and study related procedures * Willing and able to sign the informed consent form Exclusion Criteria: * Patients under the age of 18. * Pregnancy (must be ruled out in women of child-bearing age with pregnancy test) * Active infectious systemic disease * Active infectious ocular or extraocular disease * Unobstructed nasolacrimal duct in the study eye(s) * Hypersensitivity to dexamethasone * Patients being treated with immunomodulating agents in the study eye(s) * History of prior ocular surgery, including Lasik or PRK * History of ocular inflammation or macular edema * Patients being treated with \>375mg daily of NSAIDs o Patients on doses higher than 375mg of oral NSAIDs will be considered if they discontinue the medication 2 weeks prior to the study start date. * Patients taking inconsistent varying doses of an NSAID on a daily basis. * Patients being treated with immunosuppressants and/or oral steroids * Patients with a corticosteroid implant (i.e. Ozurdex) * Patients with severe disease that warrants critical attention, deemed unsafe for the study by the investigator